Adjuvant therapy with imatinib in gastrointestinal stromal tumors (GISTs)—review and perspectives

Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumor of the gastrointestinal (GI) tract. Most of them (>75%) are driven by an oncogenic initiating event involving activating mutations of the genes encoding for tyrosine kinase, KIT or platelet derived growth factor recepto...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Gastroenterol Hepatol
Main Authors: Laurent, Marie, Brahmi, Mehdi, Dufresne, Armelle, Meeus, Pierre, Karanian, Marie, Ray-Coquard, Isabelle, Blay, Jean-Yves
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2019
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6509420/
https://ncbi.nlm.nih.gov/pubmed/31143845
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tgh.2019.03.07
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados